Skip to main content
. 2023 May 24;85(7):715–720. doi: 10.1292/jvms.23-0110

Table 2. Comparison of sulfadiazine (SDZ) and sulfamonomethoxine (SMM) oral pharmacokinetics in Holstein cows (n=4) after their intravenous (5 mg/kg BW) and oral administration (10 mg/kg BW).

Parameters Units SDZ SMM
Mean ± SD Mean ± SD
ka hr−1 0.158 ± 0.029 0.179 ± 0.023*
t1/2ka hr 4.51 ± 0.82 3.91 ± 0.51*
kel hr−1 0.262 ± 0.027 0.433 ± 0.058*
t1/2kel hr 2.66 ± 0.25 1.62 ± 0.24*
Cmax µg/mL 7.01 ± 0.50 4.29 ± 0.32*
Tmax hr 5.00 ± 1.15 2.75 ± 0.96*
F % 85.7 ± 2.7 89.5 ± 7.3
MAT hr 5.92 ± 1.11 5.24 ± 0.69*
MRTi.v. hr 3.69 ± 0.32 2.21 ± 0.31*
MRTp.o. hr 9.61 ± 1.27 7.45 ± 0.66*
AUCi.v. µg/hr/mL 52.0 ± 6.5 25.1 ± 3.0*
AUCp.o. µg/hr/mL 98.5 ± 13.1 45.6 ± 6.0*
CLtot L/hr/kg 0.0973 ± 0.0118 0.202 ± 0.023*
Vdss L/kg 0.357 ± 0.027 0.445 ± 0.081

ka=primary absorption rate constant; t1/2ka=absorption half-life; kel=primary elimination rate constant; t1/2kel=elimination half-life; Cmax=maximum blood concentration; Tmax=time to maximum plasma concentration; F=oral bioavailability percentage; MAT=Mean absorption time; MRTi.v.=average residence time during intravenous administration; MRTp.o.=average residence time during oral administration; AUCi.v.=area under the plasma concentration-time curve after intravenous injection; AUCp.o.=area under the plasma concentration-time curve after oral administration; CLtot=total body clearance; Vdss=distribution volume at steady state.